Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic Prophylaxis in High-Risk Groin Hernia Repair
NCT06576154Phase 3Recruiting
- Sponsor
- University of Aleppo
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of cefazolin in surgical site infection (SSI), sponsored by University of Aleppo. Started Aug 2024; status: recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06576154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06576154.